CoChat
Sign Up
Cited by 47

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Impact of atomoxetine on subjective attention and memory difficulties in perimenopausal and postmenopausal women

Epperson, C. Neill, Pittman, Brian, Czarkowski, Kathryn A., Bradley, Jeanette, Quinlan, Donald M., Brown, Thomas E.·2011·Menopause
DOI 10.1097/gme.0b013e3181fcafd6PMC PMC4076798
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/gme.0b013e3181fcafd6

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 6 references

Research works printed but not linked: 38

  1. Mitchell, 2001, Midlife women's attributions about perceived memory changes: observations from the Seattle Midlife Women's Health Study., J Womens Health Gend Based Med, 10, 351, 10.1089/152460901750269670 · DOI
  2. Fuh, 2006, A longitudinal study of cognition change during early menopausal transition in a rural community., Maturitas, 53, 447, 10.1016/j.maturitas.2005.07.009 · DOI
  3. Henderson, 2003, Estrogen exposures and memory at midlife: a population-based study of women., Neurology, 60, 1369, 10.1212/01.WNL.0000059413.75888.BE · DOI
  4. Luetters, 2007, Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the Study of Women's Health Across the Nation (SWAN)., J Womens Health, 16, 331, 10.1089/jwh.2006.0057 · DOI
  5. Halbreich, 1995, Possible acceleration of age effects on cognition following menopause., J Psychiatr Res, 29, 153, 10.1016/0022-3956(95)00005-P · DOI
  6. Kok, 2006, Cognitive function across the life course and the menopausal transition in a British birth cohort., Menopause, 13, 19, 10.1097/01.gme.0000196592.36711.a0 · DOI
  7. Krug, 2006, A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women., Psychoneuroendocrinology, 31, 965, 10.1016/j.psyneuen.2006.05.007 · DOI
  8. Stevens, 2005, Low-dose estradiol alters brain activity., Psychiatry Res, 139, 199, 10.1016/j.pscychresns.2005.04.004 · DOI
  9. Voytko, 2009, Executive function and attention are preserved in older surgically menopausal monkeys receiving estrogen or estrogen plus progesterone., J Neurosci, 29, 10362, 10.1523/JNEUROSCI.1591-09.2009 · DOI
  10. Wegesin, 2007, Effects of hormone replacement therapy and aging on cognition: evidence for executive dysfunction., Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 14, 301, 10.1080/13825580600802893 · DOI
  11. Arnsten, 2009, Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction., CNS Drugs, 23, 33, 10.2165/00023210-200923000-00005 · DOI · Paper page
  12. Joffe, 2006, Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women., Menopause, 13, 411, 10.1097/01.gme.0000189618.48774.7b · DOI
  13. Simpkins, 2008, More than a decade of estrogen neuroprotection., Alzheimer Dement, 4, S131, 10.1016/j.jalz.2007.10.009 · DOI
  14. Suzuki, 2006, Mechanisms of neuroprotection by estrogen., Endocrine, 29, 209, 10.1385/ENDO:29:2:209 · DOI
  15. Amin, 2005, Effect of estrogen-serotonin interactions on mood and cognition., Behav Cogn Neurosci Rev, 4, 43, 10.1177/1534582305277152 · DOI
  16. Sherwin, 2008, Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review., Front Neuroendocrinol, 29, 88, 10.1016/j.yfrne.2007.08.002 · DOI
  17. Shumaker, 2003, Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial., JAMA, 289, 2651, 10.1001/jama.289.20.2651 · DOI · Paper page
  18. Zandi, 2002, Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study., JAMA, 288, 2123, 10.1001/jama.288.17.2123 · DOI
  19. Sherwin, 1996, "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri., J Clin Endocrinol Metab, 81, 2545
  20. Shifren, 2010, Role of hormone therapy in the management of menopause., Obstet Gynecol, 115, 839, 10.1097/AOG.0b013e3181d41191 · DOI
  21. Bymaster, 2002, Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder., Neuropsychopharmacology, 27, 699, 10.1016/S0893-133X(02)00346-9 · DOI · Paper page
  22. Gehlert, 1995, Novel halogenated analogs of atomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain., Neurochem Int, 26, 47, 10.1016/0197-0186(94)00113-9 · DOI
  23. Adler, 2009, Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial., J Clin Psychopharmacol, 29, 44, 10.1097/JCP.0b013e318192e4a0 · DOI
  24. Koda, 2010, Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice., J Neurochem, 114, 259, 10.1111/j.1471-4159.2010.06750.x · DOI · Paper page
  25. Seidman, 1998, Neuropsychological function in adults with attention-deficit hyperactivity disorder., Biol Psychiatry, 44, 260, 10.1016/S0006-3223(97)00392-2 · DOI
  26. Kooij, 2008, Reliability, validity and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients., J Atten Disord, 11, 445, 10.1177/1087054707299367 · DOI · Paper page
  27. Hervey, 2004, Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review., Neuropsychology, 18, 485, 10.1037/0894-4105.18.3.485 · DOI · Paper page
  28. Lokken, 2006, The relationship between menopausal status, phase of menstrual cycle, and replacement estrogen on cognition in healthy women without dementia., J Psychol, 140, 533, 10.3200/JRLP.140.6.533-547 · DOI
  29. Maki, 2007, Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial., Neurology, 69, 1322, 10.1212/01.wnl.0000277275.42504.93 · DOI
  30. Alhola, 2006, Estrogen therapy and cognition: a 6-year single-blind follow-up study in postmenopausal women., Neurology, 67, 706, 10.1212/01.wnl.0000230135.10179.86 · DOI
  31. Amin, 2006, Estradiol and tryptophan depletion interact to modulate cognition in menopausal women., Neuropsychopharmacology, 31, 2489, 10.1038/sj.npp.1301114 · DOI
  32. Epperson, 2007, The resistance to depressive relapse in menopausal women undergoing tryptophan depletion: preliminary findings., J Psychopharmacol, 21, 414, 10.1177/0269881106067330 · DOI
  33. Bierman, 2005, Effects of anxiety versus depression on cognition in later life., Am J Geriatr Psychiatry, 13, 686, 10.1097/00019442-200508000-00007 · DOI
  34. Beck, 1988, An inventory for measuring clinical anxiety: psychometric properties., J Consult Clin Psychol, 56, 893, 10.1037/0022-006X.56.6.893 · DOI · Paper page
  35. Biederman, 2008, Discordance between psychometric testing and questionnaire-based definitions of executive function deficits in individuals with ADHD., J Atten Disord, 12, 92, 10.1177/1087054707305111 · DOI · Paper page
  36. Stavro, 2007, Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder., J Int Neurol Soc, 13, 324
  37. Faraone, 2006, Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?, Am J Psychiatry, 163, 1720, 10.1176/ajp.2006.163.10.1720 · DOI · Paper page
  38. Shibao, 2007, Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function., Hypertension, 50, 47, 10.1161/HYPERTENSIONAHA.107.089961 · DOI

Cited by

Sorted by citations

See all 47

Metadata

Authors
Epperson, C. N., Pittman, B., Czarkowski, K. A., Bradley, J., Quinlan, D. M., & Brown, T. E.
Venue
Menopause
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2011-05
Volume
18
Issue
5
Pages
542-548
ISSN
1072-3714
DOI
10.1097/gme.0b013e3181fcafd6
PMC
PMC4076798
Cited by
47
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review